Aimwell Partners Inc (AIMN)

$0.01 0.00 (-36.36%)
Market Cap 2,000.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 698,400
Avg Vol 118,772
Day's Range N/A - N/A
Shares Out 137,000.00
Stochastic %K 8%
Beta 1,482.59
Analysts Strong Buy
Price Target N/A

Company Profile

Lee Pharmaceuticals, Inc. provides personal care products in the United States. The company offers aloe vera products, antacids, cosmetics and douches, cough and cold products, depilatories and waxes, laxatives, lip balm products, men's personal care products, monticello drugs, oral care products, pain relievers, skin care products, tobacco accessories, topical ointments and creams, baby care products, and vitamins and nutritional products, as well as nasal sprays, lip conditioners, and over the...

Industry: Software - Application
Sector: Technology
Phone: 307-278-1360
Address:
11 N Water Street, Mobile, United States
SmallCapGrowth
SmallCapGrowth May. 12 at 4:33 PM
$BCTX Phase 3 update: • 230+ patients enrolled in Bria-IMT trial • Strong site & patient demand • Interim results expected in 2026 Potential path toward approval in metastatic breast cancer if survival data is positive. NEWS: https://t.co/m0s9bNNz4n $ILLR $AIMN $VNRX
0 · Reply
UltimateTrader_22
UltimateTrader_22 May. 7 at 4:43 PM
Bullish on $AIMN Strong early demand for AimwellBio’s FHIN Founding Cohort as it fights AI hallucinations with verified, traceable intelligence. Expanding fast in healthcare AI! #AIMN : Video Detail : Understand more about https://aimwellbio.com https://x.com/AimwellBIO/status/2052005489311916440
0 · Reply
MikeTechnician
MikeTechnician May. 7 at 12:32 PM
$AIMN - News : While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. ~~~~~~~~~~~~~~~~~~~~~~~~~ AimwellBio's live signal intelligence engine is now tracking 13 source streams in real time - FDA actions, drug recalls, clinical trials, patent filings, global outbreaks, and regulatory divergence. It's running right now. The only question is whether you're seeing what it sees. https://finance.yahoo.com/sectors/healthcare/articles/while-were-meeting-14-signals-123000642.html
0 · Reply
DACEMC
DACEMC May. 7 at 10:42 AM
$AIMN $AIMN bringing real innovation to healthcare AI 🚀 Verified, trustworthy medical intelligence could be a game changer for clinicians and patients alike.
0 · Reply
SunInABottle
SunInABottle May. 6 at 6:08 PM
$AIMN
0 · Reply
762user
762user May. 6 at 5:31 PM
$AIMN This has possibilities. It doesn’t take much volume for the price to rise.
0 · Reply
MikeTechnician
MikeTechnician May. 6 at 1:22 PM
$AIMN Most people still don’t understand how dangerous unverified AI can become inside healthcare systems. This short video explains exactly why AimwellBio exists. Please watch. 👇 https://x.com/AimwellPartners/status/2052006024345731493
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 6 at 1:07 PM
$AIMN — 14 signals moved while you were in that meeting. AimwellBio’s live Signal Intelligence now tracks 13 real-time streams — FDA actions, recalls, trials, patents, outbreaks. Are you watching? Read more: https://wix.to/1vB7XhU #AIMN #Biotech #MarketIntel @frontpagestocks
0 · Reply
UltimateTrader_22
UltimateTrader_22 May. 6 at 12:44 PM
$AIMN NEWS: AimwellBio's live signal intelligence engine is now tracking 13 source streams in real time - FDA actions, drug recalls, clinical trials, patent filings, global outbreaks, and regulatory divergence. It's running right now. The only question is whether you're seeing what it sees. https://www.accessnewswire.com/newsroom/en/business-and-professional-services/while-you-were-in-that-meeting-14-signals-moved.-your-competitor-1164121 @AimwellBIO @AimwellPartners
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 5 at 7:05 PM
$AIMN Aimwell Partners launches AimwellBio — a verified intelligence layer to combat AI hallucinations in clinical settings. Critical as hospitals scale AI use. Read more: https://wix.to/qgN1aDk #AI #Healthcare #MedTech #AIMN @frontpagestocks
0 · Reply
Latest News on AIMN
No data available.
SmallCapGrowth
SmallCapGrowth May. 12 at 4:33 PM
$BCTX Phase 3 update: • 230+ patients enrolled in Bria-IMT trial • Strong site & patient demand • Interim results expected in 2026 Potential path toward approval in metastatic breast cancer if survival data is positive. NEWS: https://t.co/m0s9bNNz4n $ILLR $AIMN $VNRX
0 · Reply
UltimateTrader_22
UltimateTrader_22 May. 7 at 4:43 PM
Bullish on $AIMN Strong early demand for AimwellBio’s FHIN Founding Cohort as it fights AI hallucinations with verified, traceable intelligence. Expanding fast in healthcare AI! #AIMN : Video Detail : Understand more about https://aimwellbio.com https://x.com/AimwellBIO/status/2052005489311916440
0 · Reply
MikeTechnician
MikeTechnician May. 7 at 12:32 PM
$AIMN - News : While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. ~~~~~~~~~~~~~~~~~~~~~~~~~ AimwellBio's live signal intelligence engine is now tracking 13 source streams in real time - FDA actions, drug recalls, clinical trials, patent filings, global outbreaks, and regulatory divergence. It's running right now. The only question is whether you're seeing what it sees. https://finance.yahoo.com/sectors/healthcare/articles/while-were-meeting-14-signals-123000642.html
0 · Reply
DACEMC
DACEMC May. 7 at 10:42 AM
$AIMN $AIMN bringing real innovation to healthcare AI 🚀 Verified, trustworthy medical intelligence could be a game changer for clinicians and patients alike.
0 · Reply
SunInABottle
SunInABottle May. 6 at 6:08 PM
$AIMN
0 · Reply
762user
762user May. 6 at 5:31 PM
$AIMN This has possibilities. It doesn’t take much volume for the price to rise.
0 · Reply
MikeTechnician
MikeTechnician May. 6 at 1:22 PM
$AIMN Most people still don’t understand how dangerous unverified AI can become inside healthcare systems. This short video explains exactly why AimwellBio exists. Please watch. 👇 https://x.com/AimwellPartners/status/2052006024345731493
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 6 at 1:07 PM
$AIMN — 14 signals moved while you were in that meeting. AimwellBio’s live Signal Intelligence now tracks 13 real-time streams — FDA actions, recalls, trials, patents, outbreaks. Are you watching? Read more: https://wix.to/1vB7XhU #AIMN #Biotech #MarketIntel @frontpagestocks
0 · Reply
UltimateTrader_22
UltimateTrader_22 May. 6 at 12:44 PM
$AIMN NEWS: AimwellBio's live signal intelligence engine is now tracking 13 source streams in real time - FDA actions, drug recalls, clinical trials, patent filings, global outbreaks, and regulatory divergence. It's running right now. The only question is whether you're seeing what it sees. https://www.accessnewswire.com/newsroom/en/business-and-professional-services/while-you-were-in-that-meeting-14-signals-moved.-your-competitor-1164121 @AimwellBIO @AimwellPartners
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 5 at 7:05 PM
$AIMN Aimwell Partners launches AimwellBio — a verified intelligence layer to combat AI hallucinations in clinical settings. Critical as hospitals scale AI use. Read more: https://wix.to/qgN1aDk #AI #Healthcare #MedTech #AIMN @frontpagestocks
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 5 at 2:18 PM
Aimwell Partners $AIMN sees strong early-stage interest from hospital systems and researchers for its FHIN founding cohort. Early engagement could accelerate federated health intelligence adoption. Read more: https://wix.to/bdYp7Sn #AIMN #HealthTech #FHIN @DACE0325 @frontpagestocks
0 · Reply
BlazingStocks
BlazingStocks May. 5 at 2:10 PM
$AIMN News April 27, 2026 AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings https://finance.yahoo.com/sectors/healthcare/articles/aimwellbio-launches-verified-intelligence-layer-123000706.html
0 · Reply
DACEMC
DACEMC May. 5 at 1:05 PM
$AIMN $AIMN is starting to look like one of those under-the-radar plays that suddenly gets attention for the right reasons. With the company now current and no longer pink limited, that alone removes a major barrier for investors who’ve been sitting on the sidelines. Transparency and compliance matter—and $AIMN just checked that box. What really stands out is their push into healthcare AI, especially addressing one of the biggest risks in the space right now: hallucinations in clinical decision-making. If their verified intelligence layer gains traction, that’s not just hype—that’s real-world utility in a sector that demands accuracy. Low float + improving fundamentals + timely positioning in AI healthcare = a setup worth watching closely.
0 · Reply
Robere
Robere May. 4 at 9:22 PM
$AIMN even though the news is good, the only red flag about this is all that dumping be cautious and good luck
0 · Reply
BlazingStocks
BlazingStocks May. 4 at 7:30 PM
$AIMN - John Morgan, who led the initial hospital engagement, confirmed that the meeting exceeded expectations. The hospital system in question is now evaluating a potential phased onboarding of its research division as the first step toward potential institutional participation in the FHIN contributor network. https://finance.yahoo.com/sectors/healthcare/articles/aimwellbio-reports-strong-early-demand-123000432.html
0 · Reply
BlazingStocks
BlazingStocks May. 4 at 4:15 PM
$AIMN News May 04, 2026 AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape https://finance.yahoo.com/sectors/healthcare/articles/aimwellbio-reports-strong-early-demand-123000432.html
0 · Reply
SmallCapGrowth
SmallCapGrowth May. 4 at 1:29 PM
🚨 $AIMN ON HIGH ALERT 🚨 AimwellBio just reported strong early demand from hospital systems and researchers as its FHIN founding cohort begins taking shape. 🧠⚕️ The healthcare AI trust layer narrative is heating up: ✅ Hospital-system interest in onboarding research staff ✅ FHIN enrollment timeline accelerating ✅ More hospitalist + clinical researcher meetings scheduled ✅ AIMWELL Cortex targets AI hallucination risk ✅ Verified, source-traceable clinical + regulatory intelligence ✅ Healthcare RegTech angle gaining momentum AI in medicine needs trust, verification, and traceability — and $AIMN is positioning right in that gap. 👀📈 #AIMN #AI #HealthcareAI #Biotech #RegTech #OTCStocks @frontpagestocks @DACE0325 @hedgestreetcap https://www.tiktok.com/@stocksonhighalert/video/7636026716154088725
0 · Reply